Editors' Pick No evidence of disease activity: indirect comparisons of oral therapies for the treatment of relapsing-remitting multiple sclerosis. Nixon R, Bergvall N, Tomic D, Sfikas N, Cutter G, Giovannoni G Adv Ther. 2014 Nov; 31(11):1134-54. Epub 2014 Nov 21. PMID: 25414048. Abstract CommentRecommendBookmarkWatch